The World Health Organization (WHO) released a report stating that Cannabidiol (CBD) carries no risk of addiction or dependence. And they added that to date, there isn't any evidence of public health risks or recreational use surrounding CBD.
The FDA announced their approval of a clinical trial evaluating CBD as a treatment for opioid use disorder, which will be conducted at the University of California, Los Angeles.
They FDA has also announced that they will be conducting thorough studies into CBD and its effects on humans due to the significant public interest in cannabis and cannabis-derived compounds.